Philadelphia+ Chronic Myeloid Leukemia with CALR Mutation: A Case Report and Literature Review
Seug Yun Yoon, Sun Young Jeong, Changgon Kim, Min-Young Lee, Jieun Kim, Kyoung-Ha Kim, Namsu Lee, Jong-Ho Won
Cancer Res Treat. 2020;52(3):987-991. Published online 2020 Jan 15 DOI: https://doi.org/10.4143/crt.2019.703
Citations to this article as recorded by 
Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination
Magda Zanelli, Alessandra Bisagni, Francesca Sanguedolce, Giuseppe Broggi, Valentina Fragliasso, Maurizio Zizzo, Andrea Palicelli, Giovanni Martino, Camilla Cresta, Cecilia Caprera, Matteo Corsi, Pietro Gentile, Fabrizio Gozzi, Domenico Trombetta, Paola P
Frontiers in Oncology.2024;[Epub] CrossRef
Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib
Li Huo, Jundan Xie, Qian Wang, Hongjie Shen, Zixuan Ding, Lijun Wen, Zhao Zeng, Yi Xu, Changgeng Ruan, Suning Chen, Mengxing Xue
Clinical Case Reports.2023;[Epub] CrossRef
BCR::ABL1‐positive chronic myeloid leukaemia with CALR mutation
Haili Geng, Zhengjin Zheng, Shaoyuan Wang
Clinical and Experimental Pharmacology and Physiology.2023; 50(5): 425. CrossRef
Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology
Sophie Combaluzier, Julie Quessada, Norman Abbou, Robin Arcani, Antoine Tichadou, Jean Gabert, Régis Costello, Marie Loosveld, Geoffroy Venton, Yaël Berda-Haddad
Cells.2023; 12(6): 946. CrossRef
The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders
Nicholas C. P. Cross, Anna L. Godfrey, Catherine Cargo, Mamta Garg, Adam J. Mead
British Journal of Haematology.2021; 195(3): 338. CrossRef